A phase 0/surgical window-of-opportunity study in progress, evaluating evolocumab in patients with high-grade glioma or glioblastoma.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Kirit Singh, Matthew Foster, Elizabeth S. Miller, Simon Gregory, Kent J. Weinhold, David M. Ashley, Annick Desjardins, Justin Low, Katherine B. Peters, Erin Severance, Denise Jaggers, Henry S. Friedman, Margaret O. Johnson, Allan H. Friedman, Stephen T. Keir, James Emmett Herndon, Chuan-Yuan Li, Peter E. Fecci, John H. Sampson, Mustafa Khasraw
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4286298033
